About this trial
COPD is a progressive lung disease that includes emphysema and chronic bronchitis and is a major cause of morbidity and mortality worldwide. Airway clearance techniques help improve mucus removal, reduce dyspnea, and enhance quality of life in COPD patients. This study aims to compare the effects of autogenic drainage and flutter device on dyspnea, pulmonary function, and functional capacity in patients with COPD. A randomized clinical trial will be conducted at Gulab Devi Teaching Hospital using convenient sampling. Participants will be divided into two groups: Group A will receive autogenic drainage, while Group B will use the flutter device. Interventions will be performed daily for 20-30 minutes over 6 weeks. Outcome measures will include dyspnea severity scale, spirometry, and 6-minute walk test. Data will be analyzed using SPSS with significance set at p \< 0.05. The study may provide evidence for effective, non-invasive, and cost-effective management strategies for COPD patients.
Eligibility criteria
Qualifiers
Age group: Middle age adults (40-60 years), medically stable
Both gender
Diagnosis based on GOLD criteria ((FEV₁/FVC ratio < 0.70).
Moderate COPD with no acute exacerbations in the past 4-6 weeks.
Disqualifiers
Cardic Diseases (Acute MI, Congestive Heart Failure)
Musculoskeletal Impairements
Using Non-invasive Ventilation
Recent lung diseases (Respiratory failure, pneumothorax)
Trial design
Treatments tested in this trial
- Autogenic drainage
- Flutter Device